Dealmaking and Industry Outlook: Neurological Disease

Decision Resources
November 2, 2009
37 Pages - SKU: DECR2497060
License type:
World Market for Personalized Medicine Diagnostics (Biomarkers, Pharmacodiagnostics, Tumor Assays, Cardiac Risk and Other Testing)
3/1/2012 | published by: Kalorama Information
In this market research report, Kalorama Information defines the current opportunity and a realistic future potential for personalized medicine in clinical testing. In addition to analysis of tests currently on the market and in development,  |  more...
$3,795.00
Brain Hemorrhage Global Clinical Trials Review, H1, 2012
4/25/2012 | published by: GlobalData
Brain Hemorrhage Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Brain Hemorrhage Global Clinical Trials Review, H1, 2012 provides data on the Brain Hemorrhage clinical trial scenario. This report provides elemental information and data  |  more...
$1,000.00
Brain Injury Global Clinical Trials Review, H1, 2012
4/25/2012 | published by: GlobalData
Brain Injury Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Brain Injury Global Clinical Trials Review, H1, 2012 provides data on the Brain Injury clinical trial scenario. This report provides elemental information and data  |  more...
$1,000.00
Cerebral Infarction (Brain Infarction) Global Clinical Trials Review, H1, 2012
4/25/2012 | published by: GlobalData
Cerebral Infarction (Brain Infarction) Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Cerebral Infarction (Brain Infarction) Global Clinical Trials Review, H1, 2012 provides data on the Cerebral Infarction (Brain Infarction) clinical trial scenario. This  |  more...
$1,000.00
Cluster Headache Syndrome Global Clinical Trials Review, H1, 2012
4/25/2012 | published by: GlobalData
Cluster Headache Syndrome Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Cluster Headache Global Clinical Trials Review, H1, 2012 provides data on the Cluster Headache clinical trial scenario. This report provides elemental information and  |  more...
$1,000.00
Tension -Type Headache Global Clinical Trials Review, H1, 2012
4/25/2012 | published by: GlobalData
Tension -Type Headache Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Tension -Type Headache Global Clinical Trials Review, H1, 2012 provides data on the Tension -Type Headache clinical trial scenario. This report provides elemental  |  more...
$1,000.00
Traumatic Brain Injury Global Clinical Trials Review, H1, 2012
4/25/2012 | published by: GlobalData
Traumatic Brain Injury Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Traumatic Brain Injury Global Clinical Trials Review, H1, 2012 provides data on the Traumatic Brain Injury clinical trial scenario. This report provides elemental  |  more...
$1,000.00
Amyotrophic Lateral Sclerosis Global Clinical Trials Review, H1, 2012
4/25/2012 | published by: GlobalData
Amyotrophic Lateral Sclerosis Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Amyotrophic Lateral Sclerosis Global Clinical Trials Review, H1, 2012 provides data on the Amyotrophic Lateral Sclerosis clinical trial scenario. This report provides elemental  |  more...
$1,000.00
Brain Ischemia Global Clinical Trials Review, H1, 2012
4/25/2012 | published by: GlobalData
Brain Ischemia Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Brain Ischemia Global Clinical Trials Review, H1, 2012 provides data on the Brain Ischemia clinical trial scenario. This report provides elemental information and data  |  more...
$1,000.00
Narcolepsy Therapeutics - Pipeline Assessment and Market Forecasts to 2019
2/29/2012 | published by: GlobalData
Narcolepsy Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Summary GlobalData, the industry analysis specialist, has released its new report, “Narcolepsy Therapeutics - Pipeline Assessment and Market Forecasts to 2019”. The report is an essential source  |  more...
$3,995.00